Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.474, 2005-01, pp. : 5-5
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
The pros and cons of Rx-to-OTC switching of drugs in the US
Inpharma, Vol. 1, Iss. 1480-1481, 2005-01 ,pp. :
Access to resources
Recommend
Third party Rx-to-OTC switching in the US?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 362, 2002-01 ,pp. :
The Pros and Cons of a Single Euro-Price For Drugs
By Towse A.
PharmacoEconomics, Vol. 13, Iss. 3, 1998-03 ,pp. :
Pros and Cons for the Development of New Antiepileptic Drugs
By Bialer M.
CNS Drugs, Vol. 16, Iss. 5, 2002-01 ,pp. :
No adverse effect of Rx-to-OTC switch for H2RAs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 475, 2005-01 ,pp. :